• Siontis KC, et al.. Outcomes associated with apixaban use in end-stage kidney disease patients with atrial fibrillation in the United States. Circulation 2018. http://doi.org/10.1161/CIRCULATIONAHA.118.035418].

    • Crossref
    • Search Google Scholar
    • Export Citation

Apixaban Said to Lower Bleeding Risk in Dialysis Patients with Atrial Fibrillation

Restricted access
Save